-
Evolving Use of Health Technology Assessment in Medical Device Procurement—Global Systematic Review
-
Recommendations on the Selection, Development, and Modification of Performance Outcome (PerfO) Assessments
-
Quantitative Benefit-Risk Assessment in Medical Product Decision Making
-
A Roadmap for Increasing the Usefulness and Impact of Patient-Preference Studies in Decision Making in Health
-
HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects
-
Machine Learning Methods in Health Economics and Outcomes Research—The PALISADE Checklist
-
Designing and Implementing Deliberative Processes for Health Technology Assessment: Joint HTAi/ISPOR Task Force Report
-
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022)
-
Critical Appraisal of Systematic Reviews With Costs and Cost-Effectiveness Outcomes: An ISPOR Good Practices Task Force Report
-
Improving Transparency to Build Trust in Real-World Secondary Data Studies - Real-World Evidence Transparency Initiative
-
Value of Information Analytical Methods - Report 2
-
Value of Information Analysis for Research Decisions - An Introduction Report 1
-
Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models
-
Economic Analysis of Vaccination Programs - Good Practices for Outcomes Research Task Force Report
-
Application of Constrained Optimization Methods in Health Services Research
-
Good Practices for Real-World Data Studies of Treatment and/or Comparative Effectiveness
-
Patient-Reported Outcome and Observer-Reported Outcome Assessment in Rare Disease Clinical Trials
-
Constrained Optimization Methods in Health Services Research-An Introduction
-
Mapping to Estimate Health-State Utility from Non-Preference-Based Outcome Measures
-
Clinician-Reported Outcome Assessments of Treatment Benefit-Clinical Outcome Assessment Emerging Good Practices Task Force
Questions?
For any questions about this report please contact us.